Evidence map›Paper›PMID 21255330›Full record

ArticleMicrobial biotechnology2010

Ribose utilization by the human commensal Bifidobacterium breve UCC2003.

Karina Pokusaeva, Ana Rute Neves, Aldert Zomer, Mary O'Connell-Motherway, John MacSharry, Peter Curley, Gerald F Fitzgerald, Douwe van Sinderen

Abstract read
In one paragraph

Article in Microbial biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Plant Glycan Metabolism by Bifidobacteria.Frontiers in microbiology · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Karina PokusaevaAlimentary Pharmabiotic Centre, Department of Microbiology, University College Cork, Western Road, Cork, Ireland.
Ana Rute Neves
Aldert Zomer
Mary O'Connell-Motherway
John MacSharry
Peter Curley
Gerald F Fitzgerald
Douwe van Sinderen
University College Cork · IEUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth of Bifidobacterium breve UCC2003 on ribose leads to the transcriptional induction of the rbsACBDK gene cluster. Generation and phenotypic analysis of an rbsA insertion mutant established that the rbs gene cluster is essential for ribose utilization, and that its transcription is likely regulated by a LacI-type regulator encoded by rbsR, located immediately upstream of rbsA. Gel mobility shift assays using purified RbsR(His) indicate that the promoter upstream of rbsABCDK is negatively controlled by RbsR(His) binding to an 18 bp inverted repeat and that RbsR(His) binding activity is modulated by D-ribose. The rbsK gene of the rbs operon of B. breve UCC2003 was shown to specify a ribokinase (EC 2.7.1.15), which specifically directs its phosphorylating activity towards D-ribose, converting this pentose sugar to ribose-5-phosphate.

Indexed as

BifidobacteriumDNA, BacterialElectrophoretic Mobility Shift AssayGene Expression Regulation, BacterialGenes, BacterialMultigene FamilyMutagenesis, InsertionalPromoter Regions, GeneticProtein BindingRepressor ProteinsRiboseDNA, BacterialRepressor ProteinsRibose

Identifiers

PMID21255330
PMCPMC3815373
OpenAlexW2156610880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.